Annual EBIT:
$97.57M+$10.25M(+11.74%)Summary
- As of today, PCRX annual earnings before interest & taxes is $97.57 million, with the most recent change of +$10.25 million (+11.74%) on December 31, 2024.
- During the last 3 years, PCRX annual EBIT has fallen by -$35.26 million (-26.54%).
- PCRX annual EBIT is now -26.54% below its all-time high of $132.84 million, reached on December 31, 2021.
Performance
PCRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$13.15M+$4.02M(+44.02%)Summary
- As of today, PCRX quarterly earnings before interest & taxes is $13.15 million, with the most recent change of +$4.02 million (+44.02%) on September 30, 2025.
- Over the past year, PCRX quarterly EBIT has dropped by -$8.80 million (-40.08%).
- PCRX quarterly EBIT is now -70.68% below its all-time high of $44.87 million, reached on December 31, 2021.
Performance
PCRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$60.00M-$8.80M(-12.79%)Summary
- As of today, PCRX TTM earnings before interest & taxes is $60.00 million, with the most recent change of -$8.80 million (-12.79%) on September 30, 2025.
- Over the past year, PCRX TTM EBIT has dropped by -$42.01 million (-41.18%).
- PCRX TTM EBIT is now -54.65% below its all-time high of $132.30 million, reached on March 31, 2022.
Performance
PCRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PCRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +11.7% | -40.1% | -41.2% |
| 3Y3 Years | -26.5% | -39.6% | -40.9% |
| 5Y5 Years | +173.2% | -28.2% | +47.6% |
PCRX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -26.5% | +37.6% | -61.3% | +60.9% | -41.2% | +3.1% |
| 5Y | 5-Year | -26.5% | +173.2% | -70.7% | +60.9% | -54.6% | +47.6% |
| All-Time | All-Time | -26.5% | +283.1% | -70.7% | +162.7% | -54.6% | +196.5% |
PCRX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $13.15M(+44.0%) | $60.00M(-12.8%) |
| Jun 2025 | - | $9.13M(+11.7%) | $68.79M(-24.1%) |
| Mar 2025 | - | $8.18M(-72.3%) | $90.64M(-7.1%) |
| Dec 2024 | $97.57M(+11.7%) | $29.53M(+34.6%) | $97.57M(-4.3%) |
| Sep 2024 | - | $21.95M(-29.1%) | $102.01M(+0.9%) |
| Jun 2024 | - | $30.98M(+104.9%) | $101.13M(+8.3%) |
| Mar 2024 | - | $15.12M(-55.5%) | $93.42M(+7.0%) |
| Dec 2023 | $87.32M(+23.1%) | $33.97M(+61.2%) | $87.32M(+29.2%) |
| Sep 2023 | - | $21.08M(-9.4%) | $67.60M(-1.0%) |
| Jun 2023 | - | $23.26M(+158.0%) | $68.30M(+17.3%) |
| Mar 2023 | - | $9.02M(-36.7%) | $58.21M(-17.9%) |
| Dec 2022 | $70.93M(-46.6%) | $14.24M(-34.6%) | $70.93M(-30.2%) |
| Sep 2022 | - | $21.78M(+65.3%) | $101.55M(-8.1%) |
| Jun 2022 | - | $13.18M(-39.4%) | $110.49M(-16.5%) |
| Mar 2022 | - | $21.73M(-51.6%) | $132.30M(+0.3%) |
| Dec 2021 | $132.84M(+157.9%) | $44.87M(+46.1%) | $131.88M(+17.2%) |
| Sep 2021 | - | $30.72M(-12.2%) | $112.57M(+12.4%) |
| Jun 2021 | - | $34.99M(+64.2%) | $100.16M(+68.5%) |
| Mar 2021 | - | $21.31M(-16.6%) | $59.44M(+15.4%) |
| Dec 2020 | $51.52M(+44.3%) | $25.55M(+39.5%) | $51.52M(+26.7%) |
| Sep 2020 | - | $18.31M(+419.6%) | $40.65M(+25.6%) |
| Jun 2020 | - | -$5.73M(-142.8%) | $32.37M(-30.8%) |
| Mar 2020 | - | $13.39M(-8.8%) | $46.77M(+35.6%) |
| Dec 2019 | $35.71M(+45.3%) | $14.68M(+46.3%) | $34.50M(+7.4%) |
| Sep 2019 | - | $10.03M(+15.6%) | $32.13M(+17.2%) |
| Jun 2019 | - | $8.68M(+683.4%) | $27.41M(+7.8%) |
| Mar 2019 | - | $1.11M(-91.0%) | $25.43M(+45.5%) |
| Dec 2018 | $24.58M(+289.5%) | $12.31M(+132.1%) | $17.48M(+27.2%) |
| Sep 2018 | - | $5.31M(-20.8%) | $13.74M(+168.3%) |
| Jun 2018 | - | $6.70M(+197.9%) | $5.12M(+139.8%) |
| Mar 2018 | - | -$6.85M(-179.8%) | -$12.87M(+35.9%) |
| Dec 2017 | -$12.97M | $8.58M(+359.0%) | -$20.07M(+35.5%) |
| Sep 2017 | - | -$3.31M(+70.7%) | -$31.11M(+36.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$11.29M(+19.7%) | -$48.76M(-11.0%) |
| Mar 2017 | - | -$14.05M(-470.9%) | -$43.92M(-36.7%) |
| Dec 2016 | -$24.92M(-363.6%) | -$2.46M(+88.3%) | -$32.12M(-8.3%) |
| Sep 2016 | - | -$20.96M(-225.3%) | -$29.66M(-726.5%) |
| Jun 2016 | - | -$6.44M(-185.9%) | -$3.59M(-176.8%) |
| Mar 2016 | - | -$2.25M(>-9900.0%) | $4.67M(-54.5%) |
| Dec 2015 | $9.46M(+283.1%) | $0.00(-100.0%) | $10.27M(-43.5%) |
| Sep 2015 | - | $5.11M(+181.0%) | $18.19M(+50.4%) |
| Jun 2015 | - | $1.82M(-45.6%) | $12.09M(+62.7%) |
| Mar 2015 | - | $3.34M(-57.8%) | $7.43M(+243.9%) |
| Dec 2014 | -$5.17M(+90.3%) | $7.92M(+904.1%) | -$5.17M(+77.4%) |
| Sep 2014 | - | -$985.00K(+65.3%) | -$22.90M(+34.1%) |
| Jun 2014 | - | -$2.84M(+69.3%) | -$34.73M(+20.9%) |
| Mar 2014 | - | -$9.26M(+5.7%) | -$43.90M(+17.6%) |
| Dec 2013 | -$53.29M(-8.1%) | -$9.82M(+23.4%) | -$53.29M(+10.1%) |
| Sep 2013 | - | -$12.81M(-6.7%) | -$59.30M(+4.7%) |
| Jun 2013 | - | -$12.01M(+35.6%) | -$62.19M(-9.5%) |
| Mar 2013 | - | -$18.64M(-17.8%) | -$56.81M(-15.2%) |
| Dec 2012 | -$49.30M(-36.6%) | -$15.83M(-0.8%) | -$49.30M(-9.1%) |
| Sep 2012 | - | -$15.71M(-137.0%) | -$45.17M(-18.3%) |
| Jun 2012 | - | -$6.63M(+40.5%) | -$38.19M(+4.8%) |
| Mar 2012 | - | -$11.14M(+4.8%) | -$40.10M(-11.1%) |
| Dec 2011 | -$36.08M(-61.3%) | -$11.70M(-34.0%) | -$36.08M(-20.0%) |
| Sep 2011 | - | -$8.73M(-2.4%) | -$30.07M(+20.9%) |
| Jun 2011 | - | -$8.53M(-19.8%) | -$38.02M(-8.3%) |
| Mar 2011 | - | -$7.12M(-25.4%) | -$35.12M(-7.7%) |
| Dec 2010 | -$22.37M(+21.6%) | -$5.68M(+66.0%) | -$32.62M(+6.1%) |
| Sep 2010 | - | -$16.69M(-196.6%) | -$34.74M(-43.7%) |
| Jun 2010 | - | -$5.63M(-22.0%) | -$24.17M(-30.3%) |
| Mar 2010 | - | -$4.62M(+40.9%) | -$18.55M(-33.1%) |
| Dec 2009 | -$28.55M(+37.1%) | -$7.81M(-27.6%) | -$13.93M(-127.6%) |
| Sep 2009 | - | -$6.12M | -$6.12M |
| Dec 2008 | -$45.36M(-74.6%) | - | - |
| Dec 2007 | -$25.99M | - | - |
FAQ
- What is Pacira BioSciences, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual EBIT year-on-year change?
- What is Pacira BioSciences, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly EBIT year-on-year change?
- What is Pacira BioSciences, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. TTM EBIT year-on-year change?
What is Pacira BioSciences, Inc. annual earnings before interest & taxes?
The current annual EBIT of PCRX is $97.57M
What is the all-time high annual EBIT for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual earnings before interest & taxes is $132.84M
What is Pacira BioSciences, Inc. annual EBIT year-on-year change?
Over the past year, PCRX annual earnings before interest & taxes has changed by +$10.25M (+11.74%)
What is Pacira BioSciences, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of PCRX is $13.15M
What is the all-time high quarterly EBIT for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly earnings before interest & taxes is $44.87M
What is Pacira BioSciences, Inc. quarterly EBIT year-on-year change?
Over the past year, PCRX quarterly earnings before interest & taxes has changed by -$8.80M (-40.08%)
What is Pacira BioSciences, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of PCRX is $60.00M
What is the all-time high TTM EBIT for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high TTM earnings before interest & taxes is $132.30M
What is Pacira BioSciences, Inc. TTM EBIT year-on-year change?
Over the past year, PCRX TTM earnings before interest & taxes has changed by -$42.01M (-41.18%)